| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Laboratoire d’Enzymologie Moléculaire, Institut de Biologie Structurale, Grenoble, France;
Unité Institut National de la Santé et de la Recherche Médicale 271, Lyon, France; and
Medical Research Council Immunochemistry Unit, Department of Biochemistry, Oxford, United Kingdom
Previous studies based on the use of human serum as a source of C have provided evidence for the C-dependent enhancement of cell infection by HIV-1. The present study was undertaken to distinguish C from other serum factors and to identify the proteins and the mechanisms involved in C-dependent cell infection by HIV-1. The classical C activation pathway was reconstituted from the proteins C1q, C1r, C1s, C4, C2, C3, factor H, and factor I; each were purified to homogeneity. A mixture of these proteins at physiological concentrations was shown to reproduce the ability of normal human serum to enhance the infection of MT2 cells by HIV-1 at low doses of virus. This enhancing effect was abolished when heat-inactivated serum and C2- or C3-depleted serum were used, and was restored upon addition of the corresponding purified proteins. A mixture of two synthetic peptides corresponding to positions 10–15 and 90–97 of human C receptor type 2 (CD21) as well as soluble CD4 both inhibited the C-dependent infection process. These data provide unambiguous evidence that HIV-1 triggers a direct activation of the classical C pathway in vitro and thereby facilitates the infection of MT2 cells at low doses of virus. These findings are consistent with a mechanism involving increased interaction between the virus opsonized by C3b-derived fragment(s) and the CD21 cell receptors and subsequent virus entry through CD4 receptors.
This article has been cited by other articles:
|
|
 |
|
  E. Horakova, O. Gasser, S. Sadallah, J. M. Inal, G. Bourgeois, I. Ziekau, T. Klimkait, and J. A. Schifferli Complement Mediates the Binding of HIV to Erythrocytes J. Immunol., September 15, 2004; 173(6): 4236 - 4241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Huisman, E. J. A. Schrauwen, S. D. Pas, J. A. Karlas, G. F. Rimmelzwaan, and A. D. M. E. Osterhaus Antibodies specific for hypervariable regions 3 to 5 of the feline immunodeficiency virus envelope glycoprotein are not solely responsible for vaccine-induced acceleration of challenge infection in cats J. Gen. Virol., July 1, 2004; 85(7): 1833 - 1841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Kishore, S. K. Gupta, M. V. Perdikoulis, M. S. Kojouharova, B. C. Urban, and K. B. M. Reid Modular Organization of the Carboxyl-Terminal, Globular Head Region of Human C1q A, B, and C Chains J. Immunol., July 15, 2003; 171(2): 812 - 820. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Bouhlal, N. Chomont, N. Haeffner-Cavaillon, M. D. Kazatchkine, L. Belec, and H. Hocini Opsonization of HIV-1 by Semen Complement Enhances Infection of Human Epithelial Cells J. Immunol., September 15, 2002; 169(6): 3301 - 3306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Tacnet-Delorme, S. Chevallier, and G. J. Arlaud {beta}-Amyloid Fibrils Activate the C1 Complex of Complement Under Physiological Conditions: Evidence for a Binding Site for A{beta} on the C1q Globular Regions J. Immunol., December 1, 2001; 167(11): 6374 - 6381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Bouhlal, J. Galon, M. D. Kazatchkine, W.-H. Fridman, C. Sautes-Fridman, and N. Haeffner Cavaillon Soluble CD16 Inhibits CR3 (CD11b/CD18)-Mediated Infection of Monocytes/Macrophages by Opsonized Primary R5 HIV-1 J. Immunol., March 1, 2001; 166(5): 3377 - 3383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. S. Hlavacek, C. Wofsy, and A. S. Perelson Dissociation of HIV-1 from follicular dendritic cells during HAART: Mathematical analysis PNAS, December 21, 1999; 96(26): 14681 - 14686. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
